SAN DIEGO, November 6, 2006
LA JOLLA PHARMACEUTICAL ANNOUNCES CONTINUED PROGRESS WITH PHASE 3 INTERNATIONAL RIQUENT® STUDY

SAN DIEGO, November 2, 2006
LA JOLLA PHARMACEUTICAL COMPANY REPORTS THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

SAN DIEGO, November 1, 2006
LA JOLLA PHARMACEUTICAL COMPANY TO PRESENT AT RODMAN & RENSHAW 8TH ANNUAL HEALTHCARE CONFERENCE

SAN DIEGO, October 12, 2006
LA JOLLA PHARMACEUTICAL PROVIDES UPDATE ON MAA APPLICATION IN EUROPE

SAN DIEGO, September 27, 2006
LA JOLLA PHARMACEUTICAL PROVIDES UPDATE ON PHASE 3 INTERNATIONAL RIQUENT® STUDY

SAN DIEGO, September 20, 2006
LA JOLLA PHARMACEUTICAL COMPANY TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE

SAN DIEGO, August 9, 2006
LA JOLLA PHARMACEUTICAL EXPANDS ENROLLMENT IN PHASE 3 INTERNATIONAL RIQUENT® STUDY

SAN DIEGO, August 3, 2006
LA JOLLA PHARMACEUTICAL COMPANY REPORTS SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

SAN DIEGO, August 2, 2006
LA JOLLA PHARMACEUTICAL DATA ON SSAO CANDIDATES PRESENTED AT INTERNATIONAL SCIENTIFIC MEETING

SAN DIEGO, July 17, 2006
MICHAEL TANSEY, M.D. JOINS LA JOLLA PHARMACEUTICAL COMPANY AS CHIEF MEDICAL OFFICER

SAN DIEGO, June 22, 2006
LA JOLLA PHARMACEUTICAL COMPANY FILES MARKETING AUTHORIZATION APPLICATION FOR EUROPEAN REGULATORY APPROVAL OF RIQUENT

San Diego - June 6, 2006
LA JOLLA PHARMACEUTICAL COMPANY TO PRESENT AT PACIFIC GROWTH AND NEEDHAM & COMPANY INVESTOR CONFERENCES

San Diego - May 4, 2006
LA JOLLA PHARMACEUTICAL COMPANY REPORTS FIRST QUARTER FINANCIAL RESULTS

San Diego - April 17, 2006
LA JOLLA PHARMACEUTICAL COMPANY TO HOST CONFERENCE CALL TO INTRODUCE NEW PRESIDENT & CEO, DEIRDRE Y. GILLESPIE, M.D.

San Diego - March 29, 2006
LA JOLLA PHARMACEUTICAL COMPANY PRESENTS AT NATIONAL AUTOIMMUNE DISEASE CONFERENCE

San Diego - March 15, 2006
LA JOLLA PHARMACEUTICAL ANNOUNCES APPOINTMENT OF DEIRDRE Y. GILLESPIE AS NEW CHIEF EXECUTIVE OFFICER

San Diego, CA - March 2, 2006
LA JOLLA PHARMACEUTICAL COMPANY REPORTS FOURTH QUARTER AND YEAR END FINANCIAL RESULTS

San Diego, CA - February 9, 2006
LA JOLLA PHARMACEUTICAL COMPANY PRESENTS AT BIO CEO & INVESTOR CONFERENCE

San Diego, CA - January 12, 2006
LA JOLLA PHARMACEUTICAL IN FULL COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS

San Diego, CA - January 11, 2006
LA JOLLA PHARMACEUTICAL COMPANY TO INITIATE MULTI-DOSE STUDY OF RIQUENT IN LUPUS PATIENTS

San Diego, CA - January 5, 2006
LA JOLLA PHARMACEUTICAL COMPANY TO PRESENT AT THE JP MORGAN 24TH ANNUAL HEALTHCARE CONFERENCE